Zachary L Taylor

Clinical implementation of pharmacogenetics and model‐informed precision dosing to improve patient care

Tomoyuki Mizuno, Alexander A Vinks, Min Dong, 2020, British journal of clinical pharmacology.

Highly Sensitive Immunoresistive Sensor for Point-Of-Care Screening for COVID-19

Zachary L Taylor, L. Starita, C. Furlong, 2022, Biosensors.

SLCO1B1 *15 allele is associated with methotrexate‐induced nausea in pediatric patients with inflammatory bowel disease

Zachary L Taylor, Lisa J. Martin, L. Ramsey, 2021, Clinical and translational science.

Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing

Zachary L Taylor, A. Vinks, T. Mizuno, 2023, CPT: pharmacometrics & systems pharmacology.

CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression

Zachary L Taylor, D. Blumberger, J. Karp, 2024, Clinical pharmacology and therapeutics.

Hypoalbuminemia in children with acute lymphoblastic leukemia: relation to asparaginase therapy and impact on high dose methotrexate elimination.

Zachary L Taylor, J. Heldrup, S. R. Christensen, 2024, Cancer chemotherapy and pharmacology.